Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Bullboard Posts
Post by rjc7on Feb 27, 2015 1:36pm
117 Views
Post# 23472892

Dudes.......

Dudes.......Options are GIVEN to employees as an incentive to keep good help WITHOUT paying them direct cash.  They are issued at usually a few pennies below the current market price and will expire usually a few years into the future if not exercised by the expiry date.  When they are "in the money" and anytime before the expiry date, they will convert the options into shares.  In order to do that they must pay for the shares at the STRIKE price.  The next traunch of options which were issued at $0.40 must be exercised by March 23, 2015.  If the option holder wants to keep all the shares, he will pay to MBX $0.40 for each share he wishes to keep.  If he hasn't got the cash in the bank to buy the shares he can sell some of his existing shares in the market (therefore at the time of this writing he'd be selling at $0.54).  He will then pay $0.40/share to MBX for the shares.  The advantage this is the cash goes directly to the company. 

The options in question that someone suggested will be extended, were already extended last year for an addtional year to March 23, 2015.  They should have expired last year but were under water at that time and the company was counting on the cash from those options had they been exercised.  Extending the expiry date until the options came "in the money" i.e. March 23, 2015, made sense as  the Company was guaranteed the cash, although a year late.
Bullboard Posts